Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses.

Yang H, Chen Y, Qiao C, He X, Zhou H, Sun Y, Yin H, Meng S, Liu L, Zhang Q, Kong H, Gu C, Li C, Bu Z, Kawaoka Y, Chen H.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):392-7. doi: 10.1073/pnas.1522643113. Epub 2015 Dec 28.

PMID:
26711995
2.

Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.

Music N, Reber AJ, Kim MC, York IA, Kang SM.

Vaccine. 2016 Jan 20;34(4):466-73. doi: 10.1016/j.vaccine.2015.12.023. Epub 2015 Dec 19.

3.

Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.

Kim JH, Liepkalns J, Reber AJ, Lu X, Music N, Jacob J, Sambhara S.

Vaccine. 2016 Jan 20;34(4):495-502. doi: 10.1016/j.vaccine.2015.11.077. Epub 2015 Dec 17.

4.

Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.

Cortina-Ceballos B, Godoy-Lozano EE, Téllez-Sosa J, Ovilla-Muñoz M, Sámano-Sánchez H, Aguilar-Salgado A, Gómez-Barreto RE, Valdovinos-Torres H, López-Martínez I, Aparicio-Antonio R, Rodríguez MH, Martínez-Barnetche J.

Genome Med. 2015 Nov 25;7(1):124. doi: 10.1186/s13073-015-0239-y.

5.

INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012.

Anna S, Burtseva E, Eropkin M, Karpova L, Zarubaev V, Smorodintseva E, Konovalova N, Danilenko D, Prokopetz A, Grudinin M, Pisareva M, Anfimov P, Stolyarov K, Kiselev O, Shevchenko E, Ivanova V, Trushakova S, Breslav N, Lvov D, Klimov A, Moen A, Cox N.

Am J Infect Dis. 2013;9(3):77-93.

6.

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials.

Zhao X, Fang VJ, Ohmit SE, Monto AS, Cook AR, Cowling BJ.

Epidemiology. 2016 Jan;27(1):143-51. doi: 10.1097/EDE.0000000000000402.

7.

Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.

Reber AJ, Kim JH, Biber R, Talbot HK, Coleman LA, Chirkova T, Gross FL, Steward-Clark E, Cao W, Jefferson S, Veguilla V, Gillis E, Meece J, Bai Y, Tatum H, Hancock K, Stevens J, Spencer S, Chen J, Gargiullo P, Braun E, Griffin MR, Sundaram M, Belongia EA, Shay DK, Katz JM, Sambhara S.

Open Forum Infect Dis. 2015 Apr 15;2(2):ofv052. doi: 10.1093/ofid/ofv052. eCollection 2015 Apr.

8.

Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.

Lee YN, Kim MC, Lee YT, Hwang HS, Lee J, Kim C, Kang SM.

PLoS One. 2015 Sep 14;10(9):e0137822. doi: 10.1371/journal.pone.0137822. eCollection 2015.

9.

Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic.

McAuley JL, Kedzierska K, Brown LE, Shanks GD.

Front Immunol. 2015 Aug 19;6:419. doi: 10.3389/fimmu.2015.00419. eCollection 2015. Review.

10.

Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?

Trombetta C, Piccirella S, Perini D, Kistner O, Montomoli E.

Vaccines (Basel). 2015 Mar 18;3(1):172-85. doi: 10.3390/vaccines3010172. Review.

11.

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E.

Vaccines (Basel). 2014 Oct 13;2(4):707-34. doi: 10.3390/vaccines2040707. Review.

12.

Influenza-associated mortality in Thailand, 2006-2011.

Aungkulanon S.

Influenza Other Respir Viruses. 2015 Aug 17. doi: 10.1111/irv.12344. [Epub ahead of print]

13.

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.

Castilla J, Guevara M, Martínez-Baz I, Ezpeleta C, Delfrade J, Irisarri F, Moreno-Iribas C.

Medicine (Baltimore). 2015 Jul;94(30):e1240. doi: 10.1097/MD.0000000000001240.

14.

The evolution within us.

Cobey S, Wilson P, Matsen FA 4th.

Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676). pii: 20140235. doi: 10.1098/rstb.2014.0235.

15.

B Cells and Functional Antibody Responses to Combat Influenza.

Lofano G, Kumar A, Finco O, Del Giudice G, Bertholet S.

Front Immunol. 2015 Jun 30;6:336. doi: 10.3389/fimmu.2015.00336. eCollection 2015. Review.

16.

Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys.

Mifsud EJ, Tan AC, Brown LE, Chua BY, Jackson DC.

Front Immunol. 2015 Jun 5;6:290. doi: 10.3389/fimmu.2015.00290. eCollection 2015.

17.

H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance.

Liu R, Moise L, Tassone R, Gutierrez AH, Terry FE, Sangare K, Ardito MT, Martin WD, De Groot AS.

Hum Vaccin Immunother. 2015;11(9):2241-52. doi: 10.1080/21645515.2015.1052197. Epub 2015 Jun 19.

18.

Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Camp JV, Bagci U, Chu YK, Squier B, Fraig M, Uriarte SM, Guo H, Mollura DJ, Jonsson CB.

J Virol. 2015 Sep;89(17):8733-48. doi: 10.1128/JVI.00817-15. Epub 2015 Jun 10.

PMID:
26063430
19.

Influenza-attributable deaths in south-eastern France (1999 to 2010): mortality predictions were undependable.

Thiberville SD, Gaudart J, Raoult D, Charrel RN.

BMC Public Health. 2015 Jun 7;15:539. doi: 10.1186/s12889-015-1887-y.

20.

Global Spatio-temporal Patterns of Influenza in the Post-pandemic Era.

He D, Lui R, Wang L, Tse CK, Yang L, Stone L.

Sci Rep. 2015 Jun 5;5:11013. doi: 10.1038/srep11013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk